Hyperlink

Global Coronavirus Partnering Deals Analysis Report 2022: Gain Access to Headline, Upfront, Milestone and Royalty Data - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 8, 2022
Biotechnology, Pharmaceutical, Health, COVID-19, Biotechnology, Hyperlink, Chapter Five, Chapter Three, Chapter One, Collection, A-Z, Chapter Four, Coronavirus diseases, Chapter Six, Chapter Two, Directory, Animal, Pharmaceutical industry, Risk management, Coronavirus

Global Coronavirus Partnering 2015 to 2022 provides the full collection of 1,450+ Coronavirus disease deals signed between the world's pharmaceutical and biotechnology companies.

Key Points: 
  • Global Coronavirus Partnering 2015 to 2022 provides the full collection of 1,450+ Coronavirus disease deals signed between the world's pharmaceutical and biotechnology companies.
  • Chapter 6 provides a comprehensive directory of all Coronavirus partnering deals by specific Coronavirus target announced since 2015.
  • In addition, a comprehensive appendix is provided with each report of all Coronavirus partnering deals signed and announced since 2015.
  • The report also includes numerous tables and figures that illustrate the trends and activities in Coronavirus partnering and dealmaking since 2015.

Global Pharma, Biotech and Diagnostics Manufacturing and Supply Partnering Deal Terms and Agreements Analysis Report 2022 - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 8, 2022
Biotechnology, Manufacturing, Other Manufacturing, Health, Pharmaceutical, Hyperlink, Actavis, Biogen, Novartis, Bausch Health, Amgen, Kyowa Hakko Kirin, Research, Roche, AstraZeneca, A-Z, Eli Lilly, Baxter, Biotechnology, Securities & Exchange Commission of Pakistan, J&J, Confidentiality, BMS, Record, Intellectual property, GSK, Merck, Availability, Fine chemical, Risk management, Property management, Lease, Petroleum, Practice of law, Pfizer, Bayer, Teva, Astellas Pharma, Takeda, Pharma

The "Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022" report has been added to ResearchAndMarkets.com's offering.
  • The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2015-2022 report provides comprehensive access to available records for over 2,700 maufacturing and supply deals, including contract documents where available.
  • The report provides a detailed understanding and analysis of how and why companies enter manufacturing and supply deals.
  • Manufacturing and supply agreements provide a popular method of maximizing the value of a product launched into a market.

Global Big Pharma Partnering Terms and Agreements Analysis Report 2022: Trends in Dealmaking in the Biopharma Industry Since 2015 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 25, 2022
Health, Pharmaceutical, U.S. Securities and Exchange Commission, Research, Record, A-Z, Securities & Exchange Commission of Pakistan, Hyperlink, Mecum Dealmakers, Big Pharma, Agreement, Fine chemical, Global

The Global Big Pharma Partnering Terms and Agreements 2015-2022s report provides comprehensive access to available deals and contract documents for over 3,400 Big Pharma deals.

Key Points: 
  • The Global Big Pharma Partnering Terms and Agreements 2015-2022s report provides comprehensive access to available deals and contract documents for over 3,400 Big Pharma deals.
  • This report provides details of the latest Big Pharma agreements announced in the life sciences since 2015.
  • The report also includes numerous tables and figures that illustrate the trends and activities in Big Pharma partnering and dealmaking since 2015.
  • Big Pharma Partnering Terms and Agreements includes:
    In Global Big Pharma Partnering Terms and Agreements 2015-2022, the available deals are listed by:

Global Specialty Pharmaceutical Partnering Analysis Report 2022: Access to 1,500 Deals and Contract Documents Signed Since 2015 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 25, 2022
Health, Pharmaceutical, It Takes Two, SEC, Review, Chapter Three, Chapter One, Orientation, Chapter Five, Research, Agreement, Chapter Six, U.S. Securities and Exchange Commission, Securities & Exchange Commission of Pakistan, Record, Chapter Four, Hyperlink, Fine chemical, Risk management, Global

The Global Specialty Pharmaceutical Partnering Terms and Agreements 2015 to 2022 report provides comprehensive access to available deals and contract documents for over 1,500 Specialty Pharmaceutical deals.

Key Points: 
  • The Global Specialty Pharmaceutical Partnering Terms and Agreements 2015 to 2022 report provides comprehensive access to available deals and contract documents for over 1,500 Specialty Pharmaceutical deals.
  • The report takes the reader through a comprehensive review Specialty Pharmaceutical deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Specialty Pharmaceutical partnering deals.
  • Chapter 6 provides a comprehensive and detailed review of Specialty Pharmaceutical partnering deals signed and announced since Jan 2015.
  • Specialty Pharmaceutical Partnering Terms and Agreements includes:
    In Global Specialty Pharmaceutical Partnering Terms and Agreements 2015 to 2022, the available deals are listed by:

Global Infectious Diseases Partnering Deal Trends, Players and Financials Analysis Report 2015-2022 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 25, 2022
Health, Infectious Diseases, Campylobacter jejuni, MRSA, SEC, Directory, Review, Yellow fever, Salmonella, Global Infectious Disease Epidemiology Network, Chapter Three, Chapter One, Respiratory syncytial virus, Orientation, Contract, RSV, Chapter Five, Research, Anthrax, FIV, Methicillin-resistant Staphylococcus aureus, Escherichia coli, Technology, Haemophilus influenzae, Common cold, HIV, Chapter Six, Foot, Chapter Two, Herpes simplex, Dengue fever, A-Z, Tetanus, Mycobacterium avium complex, Streptococcus, Clostridium difficile, Hepatitis A, Lyme disease, Chapter Four, Pseudomonas aeruginosa, African trypanosomiasis, Hyperlink, Helicobacter pylori, TB, Vaccine, Pharmaceutical industry, Haemophilus, West Nile virus, Infection, Tuberculosis, H1N1, Zika fever, Sepsis, Cytomegalovirus, Diphtheria, Malaria

The "Global Infectious Diseases Partnering 2015-2022: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Infectious Diseases Partnering 2015-2022: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
  • The Global Infectious Diseases Partnering 2015-2022 report provides comprehensive access to available deals and contract documents for over 2,900 infectious diseases deals.
  • The report takes readers through the comprehensive Infectious Diseases disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Infectious Diseases deals.
  • Chapter 6 provides a comprehensive directory of all Infectious Diseases partnering deals by specific Infectious Diseases target announced since 2015.

Global Genomics Partnering Analysis Report 2022: Trends, Leading Deals, Most Active Dealmakers, Directory, Technology Type - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 6, 2022
Biotechnology, Genetics, Health, Chapter Six, Research, Intellectual property, Securities & Exchange Commission of Pakistan, Ownership, Chapter One, A-Z, It Takes Two, SEC, Orientation, Access, Chapter Three, Confidentiality, Chapter Five, U.S. Securities and Exchange Commission, Hyperlink, Chapter Four, Review, Contract, Online gambling, Health insurance, Real estate, Risk management, Property management, Sales, Petroleum, Lease, Practice of law, Genomics

Access to 900+ Genomics partnering deals and agreements entered into by the worlds leading healthcare companies.

Key Points: 
  • Access to 900+ Genomics partnering deals and agreements entered into by the worlds leading healthcare companies.
  • The report provides a detailed understanding and analysis of how and why companies enter Genomics partnering deals.
  • In addition, a comprehensive appendix is provided organized by Genomics partnering company A-Z, deal type definitions and Genomics partnering agreements example.
  • Global Genomics Partnering Terms and Agreements 2015 to 2022 includes:
    In Global Genomics Partnering Terms and Agreements 2015 to 2022, the available contracts are listed by:

Global Gene Therapy Partnering Terms and Agreements Analysis Report/Directory 2022 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 6, 2022
Biotechnology, Genetics, Health, Stem Cells, Chapter Six, Technology, Global Genes, Research, Intellectual property, Agreement, Ownership, Chapter One, It Takes Two, SEC, Orientation, Chapter Three, Confidentiality, Chapter Five, Hyperlink, Chapter Four, Review, Contract, Medical device, Pharmaceutical industry, Risk management, Fine chemical, Property management, Sales, Petroleum, Lease, Practice of law, Gene

The "Global Gene Therapy Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Gene Therapy Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.com's offering.
  • The Global Gene Therapy Partnering Terms and Agreements 2010-2022 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies.
  • In addition, a comprehensive appendix is provided organized by Gene Therapy partnering company A-Z, deal type definitions and Gene Therapy partnering agreements example.
  • Global Gene Therapy Partnering Terms and Agreements includes:
    In Global Gene Therapy Partnering Terms and Agreements, the available contracts are listed by:

Global Pediatrics Partnering Report/Directory 2010-2022: Deals and Contract Documents for 550+ Deals - Trends, Players and Financials - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 6, 2022
Hospitals, General Health, Health, Other Health, Orientation, SEC, Chapter Six, Hyperlink, Chapter Two, Chapter Four, Technology, Chapter Three, Chapter One, Chapter Five, Research, Directory, Review, Contract, Sales, Medicine, Pediatrics

The "Global Pediatrics Partnering 2010-2022: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Pediatrics Partnering 2010-2022: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
  • Chapter 6 provides a comprehensive directory of all Pediatrics partnering deals by specific Pediatrics target announced since 2010.
  • In addition, a comprehensive appendix is provided with each report of all Pediatrics partnering deals signed and announced since 2010.
  • Global Pediatrics Partnering 2010 to 2022 includes:
    In Global Pediatrics Partnering 2010 to 2022, available deals and contracts are listed by:

Global Gynecology Partnering Deal Trends, Players and Financials Report/Directory 2010-2022 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, September 6, 2022
General Health, Other Professional Services, Professional Services, Health, Pelvic inflammatory disease, Chapter Six, Menopause, Technology, Research, HPV, Premenstrual syndrome, Finance, Players, Vaginitis, Chapter One, SEC, Orientation, CIN, Chapter Two, Chapter Three, Chapter Five, Directory, Cervical intraepithelial neoplasia, Hyperlink, Chapter Four, Adenomyosis, Primary ovarian insufficiency, Polycystic ovary syndrome, Polycystic disease, Review, Contract, Video game, Birth control, Risk management, Sales, Endometriosis, Prolapse, Infertility, Dysmenorrhea, Amenorrhea, Gynaecology

The "Global Gynecology Partnering 2010-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Gynecology Partnering 2010-2022: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.
  • The Global Gynecology Partnering 2010-2022 report provides comprehensive access to available deals and contract documents for over 490 gynecology deals.
  • The report takes readers through the comprehensive Gynecology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Gynecology deals.
  • Global Gynecology Partnering 2010 to 2022 includes:
    In Global Gynecology Partnering 2010 to 2022, available deals and contracts are listed by:

Global Metabolic Partnering Report 2022: Deal Trends, Players and Financials Analysis of 1100+ Deals Signed Since 2015 - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 18, 2022
Health, Pharmaceutical, Nutrition, Hypothyroidism, Addison's disease, Fatty liver disease, Non-alcoholic fatty liver disease, Vitamin, Liver disease, Directory, Technology, Metabolism, Diabetes insipidus, SEC, Cushing's syndrome, Chapter Four, Chapter Five, Chapter Three, Lysosomal storage disease, Diabetes, Review, NASH, Contract, Syndrome of inappropriate antidiuretic hormone secretion, Syndrome, Biotechnology, Metabolic disorder, Chapter Six, Thyroid disease, SIADH, Chapter One, Chapter Two, Gallstone, Rickets, Hyperlink, Collection, Acromegaly, Orientation, Cirrhosis, A-Z, Pharmaceutical industry, Risk management, Pheochromocytoma, Hypercalcaemia, Hypogonadism, Hypocalcemia, Hyperaldosteronism, Phenylketonuria, Hypopituitarism, Hyperthyroidism

Global Metabolic Partnering 2015 to 2022 provides the full collection of 1100+ Metabolic disease deals signed between the world's pharmaceutical and biotechnology companies since 2015.

Key Points: 
  • Global Metabolic Partnering 2015 to 2022 provides the full collection of 1100+ Metabolic disease deals signed between the world's pharmaceutical and biotechnology companies since 2015.
  • The report takes readers through the comprehensive Metabolic disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Metabolic deals.
  • In addition, a comprehensive appendix is provided with each report of all Metabolic partnering deals signed and announced since 2015.
  • Global Metabolic Partnering 2015 to 2022 includes:
    In Global Metabolic Partnering 2015 to 2022, available deals and contracts are listed by: